Publishing Details
Contact & Outreach
About This Podcast
Explore Statistics
Recent Episodes
Issue 46 — Spray-Dried Dispersions
In this issue, we examine spray-dried dispersions (SDDs) as an effective method to improve solubility and bioavailability of your active pharmaceutical ingredient (API) in early-phase drug…
Issue 45 — Discovery Studies: An Agile Approach to Early Data for Quicker Decisions
In this issue, we explore the characteristics and advantages of non-GLP discovery studies, along with emerging trends in this important early phase of drug development research. We also present two…
Issue 44 — The Importance of Cytokine Release Assays to Derisk the Development of Immunomodulatory Drugs
In this issue of The Altascientist, we review strategies, including those implemented at Altasciences, for developing, qualifying, and implementing CRAs to assess the safety of test articles in vitro…
Issue 43 — Advancing Vision Care With Formulation and Manufacture of Ocular Therapeutics
According to the World Health Organization, at least a billion people are currently living with vision impairment from a preventable or treatable source. The main conditions causing their distance…
Issue 42 — Managing the Complexities of Glucagon -like Peptide-1 Receptor Agonist Drug Development
Current and future development of glucagon-like peptide-1 receptor agonists, more commonly referred to as GLP-1 RAs, or simply as GLP-1s, involves complexities not only in formulation but in all…
Issue 41 — Immunomodulation Assessments for Clinical Trials
Immunomodulatory drug development is trending toward increasingly complex modalities as science advances and more effective and safe immunotherapies are needed. Immunomodulatory drugs are at the…
Frequently Asked Questions
Altasciences has published 6 episodes since September 2024, covering topics in Science.
Altasciences is currently declining with new episodes monthly. Average episode length is 23m.
Sign up on Grep.FM to access contact details for Altasciences, including email and social media links.
